Comprehend
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Seed | |
$1.2m | Seed | ||
N/A | Seed | ||
$8.5m | Series A | ||
$21.0m | Series B | ||
$15.0m | Series C | ||
N/A | $5.0m | Early VC | |
N/A | Acquisition | ||
Total Funding | €46.1m |
Recent News about Comprehend
EditComprehend Systems, Inc., now merged with Saama Technologies, Inc., focuses on transforming the drug development ecosystem through AI-powered clinical analytics. The company serves pharmaceutical companies, clinical research organizations (CROs), and healthcare providers. Operating in the healthcare and pharmaceutical market, Comprehend offers a platform that leverages artificial intelligence to provide predictive analytics and optimize data insights. This helps clients accelerate the development and market entry of new medical treatments. The business model revolves around providing subscription-based access to their analytics platform, generating revenue through recurring fees. The merger with Saama Technologies aims to enhance their technological capabilities and market reach, promising significant advancements in AI-driven solutions for drug development.
Keywords: AI, clinical analytics, drug development, pharmaceutical, predictive insights, healthcare, CRO, data optimization, Saama Technologies, subscription model.